HK1041434A1 - 抗病毒藥物和乙型肝炎疫苗的聯合 - Google Patents
抗病毒藥物和乙型肝炎疫苗的聯合Info
- Publication number
- HK1041434A1 HK1041434A1 HK02101211.9A HK02101211A HK1041434A1 HK 1041434 A1 HK1041434 A1 HK 1041434A1 HK 02101211 A HK02101211 A HK 02101211A HK 1041434 A1 HK1041434 A1 HK 1041434A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- vaccine
- hepatitis
- combination
- antiviral agents
- antiviral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9900630 | 1999-01-12 | ||
PCT/EP1999/010295 WO2000041463A2 (fr) | 1999-01-12 | 1999-12-21 | Nouveau traitement |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1041434A1 true HK1041434A1 (zh) | 2002-07-12 |
Family
ID=10845878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02101211.9A HK1041434A1 (zh) | 1999-01-12 | 2002-02-19 | 抗病毒藥物和乙型肝炎疫苗的聯合 |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1140163A2 (fr) |
JP (1) | JP2002534438A (fr) |
KR (1) | KR20010090011A (fr) |
CN (1) | CN1391482A (fr) |
AR (1) | AR022250A1 (fr) |
AU (1) | AU760574B2 (fr) |
BR (1) | BR9916893A (fr) |
CA (1) | CA2359110A1 (fr) |
CO (1) | CO5241355A1 (fr) |
CZ (1) | CZ20012544A3 (fr) |
HK (1) | HK1041434A1 (fr) |
HU (1) | HUP0105070A2 (fr) |
IL (1) | IL144186A0 (fr) |
NO (1) | NO20013337L (fr) |
NZ (1) | NZ512890A (fr) |
PL (1) | PL349347A1 (fr) |
TR (1) | TR200102024T2 (fr) |
WO (1) | WO2000041463A2 (fr) |
ZA (1) | ZA200105690B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999061056A2 (fr) | 1998-05-22 | 1999-12-02 | Loeb Health Research Institute At The Ottawa Hospital | Methodes et produits permettant d'induire une immunite au niveau des muqueuses |
CN1560078B (zh) | 1998-07-31 | 2011-06-22 | 株式会社国际癌症免疫研究所 | 基于癌抑制基因wt1的产物的癌抗原 |
CA2440303C (fr) | 2001-03-22 | 2013-03-19 | Haruo Sugiyama | Peptide modifie wt1 |
US8735357B2 (en) | 2001-09-28 | 2014-05-27 | International Institute Of Cancer Immunology, Inc. | Method of inducing antigen-specific T cells |
JPWO2003028758A1 (ja) * | 2001-09-28 | 2005-01-13 | 治夫 杉山 | 抗原特異的t細胞の誘導方法 |
MY131488A (en) * | 2002-04-08 | 2007-08-30 | Bristol Myers Squibb Co | Low dose liquid entecavir formulations and use |
PT2241325E (pt) | 2002-10-29 | 2012-04-12 | Coley Pharm Gmbh | Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c |
AU2003300919A1 (en) | 2002-12-11 | 2004-06-30 | Coley Pharmaceutical Gmbh | 5' cpg nucleic acids and methods of use |
CN100443117C (zh) * | 2003-05-13 | 2008-12-17 | 深圳康泰生物制品股份有限公司 | 一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途 |
US8541167B2 (en) | 2004-06-03 | 2013-09-24 | Saint Louis University | Methods and compositions for vaccination |
AR065504A1 (es) * | 2007-02-28 | 2009-06-10 | Ct Ingenieria Genetica Biotech | Terapia combinada para el tratamiento de la hepatitis b cronica. uso. |
WO2020134682A1 (fr) * | 2018-12-24 | 2020-07-02 | 南京远大赛威信生物医药有限公司 | Préparation pharmaceutique pour le traitement de l'hépatite b, procédé de préparation s'y rapportant et utilisation associée |
EP4321173A1 (fr) * | 2021-04-07 | 2024-02-14 | Denka Company Limited | Activateur d'activité d'adjuvant et composition d'adjuvant |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2109921T3 (es) * | 1989-07-25 | 1998-02-01 | Smithkline Beecham Biolog | Nuevos antigenos y procedimientos para su preparacion. |
EP1064025B1 (fr) * | 1998-03-09 | 2006-09-13 | GlaxoSmithKline Biologicals S.A. | Compositions de vaccins combines |
-
1999
- 1999-12-21 PL PL99349347A patent/PL349347A1/xx not_active Application Discontinuation
- 1999-12-21 KR KR1020017008833A patent/KR20010090011A/ko not_active Application Discontinuation
- 1999-12-21 CN CN99816471A patent/CN1391482A/zh active Pending
- 1999-12-21 CZ CZ20012544A patent/CZ20012544A3/cs unknown
- 1999-12-21 AU AU21009/00A patent/AU760574B2/en not_active Ceased
- 1999-12-21 TR TR2001/02024T patent/TR200102024T2/xx unknown
- 1999-12-21 EP EP99965531A patent/EP1140163A2/fr not_active Withdrawn
- 1999-12-21 HU HU0105070A patent/HUP0105070A2/hu unknown
- 1999-12-21 IL IL14418699A patent/IL144186A0/xx unknown
- 1999-12-21 JP JP2000593088A patent/JP2002534438A/ja active Pending
- 1999-12-21 WO PCT/EP1999/010295 patent/WO2000041463A2/fr not_active Application Discontinuation
- 1999-12-21 CA CA002359110A patent/CA2359110A1/fr not_active Abandoned
- 1999-12-21 BR BR9916893-6A patent/BR9916893A/pt not_active IP Right Cessation
- 1999-12-21 NZ NZ512890A patent/NZ512890A/en unknown
-
2000
- 2000-01-11 AR ARP000100107A patent/AR022250A1/es not_active Application Discontinuation
- 2000-01-12 CO CO00001261A patent/CO5241355A1/es not_active Application Discontinuation
-
2001
- 2001-07-05 NO NO20013337A patent/NO20013337L/no not_active Application Discontinuation
- 2001-07-11 ZA ZA200105690A patent/ZA200105690B/xx unknown
-
2002
- 2002-02-19 HK HK02101211.9A patent/HK1041434A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20010090011A (ko) | 2001-10-17 |
TR200102024T2 (tr) | 2001-12-21 |
EP1140163A2 (fr) | 2001-10-10 |
CZ20012544A3 (cs) | 2002-01-16 |
AR022250A1 (es) | 2002-09-04 |
JP2002534438A (ja) | 2002-10-15 |
NO20013337L (no) | 2001-08-17 |
WO2000041463A3 (fr) | 2000-11-09 |
PL349347A1 (en) | 2002-07-15 |
IL144186A0 (en) | 2002-05-23 |
ZA200105690B (en) | 2002-09-25 |
NO20013337D0 (no) | 2001-07-05 |
WO2000041463A2 (fr) | 2000-07-20 |
AU2100900A (en) | 2000-08-01 |
CA2359110A1 (fr) | 2000-07-20 |
CO5241355A1 (es) | 2003-01-31 |
NZ512890A (en) | 2003-09-26 |
BR9916893A (pt) | 2001-11-20 |
HUP0105070A2 (hu) | 2002-04-29 |
AU760574B2 (en) | 2003-05-15 |
CN1391482A (zh) | 2003-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL144171A0 (en) | Quinolinecarboxamides as antiviral agents | |
EP1187827A4 (fr) | Agents antiviraux | |
HK1052878A1 (zh) | 利巴傳林-聚乙二醇化干擾素α:丙型肝炎病毒的聯合治療 | |
IL145045A0 (en) | Vaccine | |
HUS1300072I1 (hu) | Vakcina | |
HK1039278B (zh) | PEG化的干擾素-α-CCR5拮抗劑組合HIV療法 | |
HK1041434A1 (zh) | 抗病毒藥物和乙型肝炎疫苗的聯合 | |
GB9826069D0 (en) | HIV vaccine | |
GB9906815D0 (en) | Anti-neoplastic viral agents | |
IL162236A0 (en) | Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use | |
HK1045324A1 (zh) | 病毒變體 | |
GB9915204D0 (en) | Vaccine | |
IL139269A0 (en) | Hepatitis vaccine | |
GB9906437D0 (en) | Vaccine | |
EP1290230A4 (fr) | Conjugues du virus de l'hepatite c | |
GB9913327D0 (en) | Vaccine | |
AP2001002076A0 (en) | Hiv vaccine | |
GB9927353D0 (en) | Virus preparation and use | |
GB9928165D0 (en) | Baby sling | |
GB9917981D0 (en) | Viral vaccine | |
GB0012497D0 (en) | Antiviral therapy | |
GB9909072D0 (en) | Vaccine | |
IL128154A0 (en) | Conjugates of antiviral nucleosides | |
GB0030102D0 (en) | HCV vaccines | |
GB0030789D0 (en) | HCV vaccines |